Renal Reference Laboratory Services for Portland VAMC 36C26025Q0637
Summary
AI-generated · Aug 23, 2025A full-service reference laboratory contract is sought to provide donor-derived cell-free DNA (dd-cfDNA) testing for kidney transplant surveillance. The vendor will handle specimen acquisition, testing and interpretation, testing supplies, and customer service. The dd-cfDNA blood test is non-invasive and can be drawn at any phlebotomy site without scheduling interventional radiology; it supports rejection monitoring, reduces the need for invasive kidney biopsies, and shortens biopsy turnaround times to ensure timely, accurate results for the Portland-area kidney transplant program in the Western Region.
Contract type is firm-fixed-price with an indefinite-delivery framework and a maximum of $1.5 million in orders; the award was made to Eurofins Transplant Genomics, LLC, transitioning from the presolicitation description to a final, awarded arrangement.
The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department performs kidney transplants for the Western Region. Donor-derived cell-free DNA (dd-cfDNA) is a blood tests that is non-invasive for kidney transplant surveillance. The importance of the surveillance is to monitor for rejections. Rejection can lead to damage and injury to the transplanted kidney. Other benefits of the blood tests include decreasing the necessity for invasive biopsy of the transplanted kidney and subsequent turn-around-time (TAT) of the biopsy results. The blood test can be drawn at any phlebotomy site without the necessity to schedule for Interventional Radiology to perform the procedure. This full-service Reference Laboratory contract will provide services required for specimen acquisition, specimen testing and interpretation, testing supplies, and customer service. This requirement will ensure accurate and timely test results are made available to healthcare providers which will ensure high quality healthcare is provided to the Veterans at the VA Portland Health Care System.
From Presolicitation posted on Jun 17, 2025The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department performs kidney transplants for the Western Region. Donor-derived cell-free DNA (dd-cfDNA) is a blood tests that is non-invasive for kidney transplant surveillance. The importance of the surveillance is to monitor for rejections. Rejection can lead to damage and injury to the transplanted kidney. Other benefits of the blood tests include decreasing the necessity for invasive biopsy of the transplanted kidney and subsequent turn-around-time (TAT) of the biopsy results. The blood test can be drawn at any phlebotomy site without the necessity to schedule for Interventional Radiology to perform the procedure. This full-service Reference Laboratory contract will provide services required for specimen acquisition, specimen testing and interpretation, testing supplies, and customer service. This requirement will ensure accurate and timely test results are made available to healthcare providers which will ensure high quality healthcare is provided to the Veterans at the VA Portland Health Care System.
From Solicitation posted on Jun 20, 2025This is a firm fixed price Indefinite Quantity, Intefinite Delivery Contract with a maximum capacity of $1500000.00 order limit.
From Award Notice posted on Jul 29, 2025Notice history
3-
-
Solicitation Posted Jun 20, 2025View changes (2)
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Jul 02, 2025 → Jul 07, 2025
-
Award Notice LATEST Posted Jul 29, 2025
Details
Award Information
Award Notices
Posted: Jul 29, 2025
This is a firm fixed price Indefinite Quantity, Intefinite Delivery Contract with a maximum capacity of $1500000.00 order limit.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| Eurofins Transplant Genomics, LLC | QGB2L5JWUQF9 | 9RRZ6 | Lenexa, KS |
Contacts
Agency
Place of Performance
USA